Also from this source

You just read:

Celtic Pharma Announces Issuance of U.S. Patent 7,816,323 for Xerecept® in Combination with Avastin® as a Treatment for Breast and Colon Cancers

News provided by

Celtic Pharmaceutical Holdings L.P.

Oct 21, 2010, 08:00 ET